CMS Open Payments · Program Year 2024
Choice Spine, LLC
Choice Spine, LLC reported $1,022,021.06 across General Payments, Research, and Ownership to 389 physicians and teaching hospitals across 389 transactions.
- $1.0M Above-median payer
- All-tracks total
- 389 Above-median volume
- Transactions
- 389 Above-median reach
- Recipients
- +$162.9K
- General Payments vs PY2023
Choice Spine, LLC reported $1,022,021.06 across all CMS Open Payments tracks (General + Research + Ownership) to 389 physicians and teaching hospitals in Program Year 2024 - ranking #619 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,022,021.06, averaging $2.6K per recipient.
Choice Spine, LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
24/100
Total payments
F
19/100
Transaction volume
F
13/100
Physician reach
F
13/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer choice-spine-llc Choice Spine, LLC
$1.0M · #619/1,925 · 0.0% industry · PY2024
- TOT $1.0M
- RANK #619
- SHARE 0.0%
- TXN 389
- RCP 389
- CAT 4
- GEN $1.0M
- ΔGEN +$162.9K
- TOP1 23.1%
- PY 2024
Volume peers
Nearest volume peer: Varex Imaging Corporation ($1.0M)
Choice Spine, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Choice Spine, LLC's CMS-reported General Payments increased by $162.9K (+19.0%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: CHOICE SPINE, LLCPY2023: CHOICE SPINE, LLCPY2024: Choice Spine, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $859,103.46
- PY2024
- $1,022,021.06
What the Data Shows for Choice Spine, LLC
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Choice Spine, LLC that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
126 transactions worth $768.0K make "Royalty or License" the top general-payment category in the 4-category breakdown below, 75.1% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 4 types of general payments, Choice Spine, LLC's largest category was "Royalty or License" at $768.0K - 75.1% of General Payments.
Choice Spine, LLC reports 4 general-payment categories - the top three are Royalty or License (75.1%), Consulting Fee (16.7%), and Travel and Lodging (7.1%). The remaining 1 category make up 1.0% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Choice Spine, LLC divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Royalty or License | $768.0K | 126 | 75.1% |
| Consulting Fee | $170.6K | 89 | 16.7% |
| Travel and Lodging | $72.9K | 59 | 7.1% |
| Food and Beverage | $10.6K | 115 | 1.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $559,277.42 (54.7%) of $1,022,021.06 in this company's General Payments records across 80 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Choice Spine, LLC
The five named recipients with the highest reported General Payments from this company
- 1
Robert P Knetsche
$235,581.95 across 29 reported transactions
- 2
Julian P Price Jr.
$100,404.78 across 23 reported transactions
- 3
Jeffrey S Schiffman
$89,008.31 across 4 reported transactions
- 4
Paul Raymond Jeffords
$73,253.95 across 35 reported transactions
- 5
Mitchell a Hardenbrook
$61,028.43 across 4 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Choice Spine, LLC ranks #619 of 1,925 by total payments (top 32% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,065 of 1,838 by HHI (bottom 42% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- CPM Medical Consultants, LLC : $2.4K total payments, HHI 919
- Acessa Health Inc. : $767.2K total payments, HHI 919
- Ortho Development Corporation : $3.6M total payments, HHI 918
- EDW Pharma, Inc. : $2.6K total payments, HHI 916
- Onkos Surgical, Inc. : $402.3K total payments, HHI 915
- Kinex Medical Company LLC : $133.04 total payments, HHI 915
- Choice Spine, LLC (this company) : $1.0M total payments, HHI 912
- SOMAVAC Medical Solutions, Inc. : $2.8K total payments, HHI 906
- Ares Trading SA : $254.3K total payments, HHI 902
- SprintRay Inc : $106.8K total payments, HHI 897
- Siemens Medical Solutions USA, Inc. : $13.3M total payments, HHI 895
- Hyhte Holdings Inc. : $1.3M total payments, HHI 892
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Choice Spine, LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Choice Spine, LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Choice Spine, LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
PENTAX of America, Inc.
Bristol Myers Squibb Company
Qiagen, LLC
iotaMotion, Inc.
Radius Health, Inc.
Put this to use
Choice Spine, LLC ranks #619 of 1,925 by all-tracks total payments, led by "Royalty or License".
- See where Choice Spine, LLC sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Royalty or License" spend across every manufacturer, not just Choice Spine, LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.